These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 813753)

  • 1. Enhancement by prolactin of carcinogen induced mammary cancerigenesis in the male rat.
    Welsch CW; Louks G; Fox D; Brooks C
    Br J Cancer; 1975 Oct; 32(4):427-31. PubMed ID: 813753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of prolactin on carcinogen-induced leukemogenesis in Long-Evans rats.
    Welsch CW; Horowitz S; Huggins CB
    Cancer Res; 1975 Dec; 35(12):3746-9. PubMed ID: 811355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2-bromo-alpha-ergocryptine (CB-154) and tamoxifen (ICI 46,474) induced suppression of the genesis of mammary carcinomas in female rats treated with 7,12-dimethylbenzanthracene (DMBA): a comparison.
    Welsch CW; Goodrich-Smith M; Brown CK; Mackie D; Johnson D
    Oncology; 1982; 39(2):88-92. PubMed ID: 6801566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prophylaxis of rat and mouse mammary gland tumorigenesis by suppression of prolactin secretion: a reappraisal.
    Welsch CW; Goodrich-Smith M; Brown CK; Roth L
    Breast Cancer Res Treat; 1981; 1(3):225-32. PubMed ID: 6816317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-nitroso-N-methylurea-induced mammary tumors in the rat: role of prolactin and a prolactin-lowering drug.
    Gandilhon P; Mélançon R; Djiane J; Kelly PA
    J Natl Cancer Inst; 1983 Jan; 70(1):105-9. PubMed ID: 6296514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased incidence of mammary tumors in the female rat grafted with multiple pituitaries.
    Welsch CW; Jenkins TW; Meites J
    Cancer Res; 1970 Apr; 30(4):1024-9. PubMed ID: 5504344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic effect of chronic prolactin suppression and retinoid treatment in the prophylaxis of N-methyl-N-nitrosourea-induced mammary tumorigenesis in female Sprague-Dawley rats.
    Welsch CW; Brown CK; Goodrich-Smith M; Chiusano J; Moon RC
    Cancer Res; 1980 Sep; 40(9):3095-8. PubMed ID: 6893571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction by pituitary isograft of inhibitory effect of large dose of estrogen on incidence of mammary tumors induced by carcinogen in ovariectomized rats.
    Nagasawa H; Yanai R
    Int J Cancer; 1971 Nov; 8(3):463-7. PubMed ID: 5137309
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibition of mammary tumorigenesis in carcinogen-treated Lewis rats by suppression of prolactin secretion.
    Welsch CW; Brown CK; Goodrich-Smith M; Van J; Denenberg B; Anderson TM; Brooks CL
    J Natl Cancer Inst; 1979 Nov; 63(5):1211-4. PubMed ID: 116049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma hormone levels and the incidence of carcinogen-induced mammary tumours in two strains of rat.
    Hawkins RA; Drewitt D; Freedman B; Killin E; Jenner DA; Cameron EH
    Br J Cancer; 1976 Nov; 34(5):546-9. PubMed ID: 826265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression by pregnancy of chemically induced preneoplastic cells of the rat mammary gland.
    Grubbs CJ; Juliana MM; Hill DL; Whitaker LM
    Anticancer Res; 1986; 6(6):1395-400. PubMed ID: 3101578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response to adreno-ovariectomy and/or pituitary grafting of carcinogen-induced mammary tumors in rats with different growth potential.
    Nagasawa H; Yanai R; Nakajima Y
    Eur J Cancer (1965); 1980 Oct; 16(10):1345-50. PubMed ID: 6781908
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of high dietary fat on the growth and development of ovarian-independent carcinogen-induced mammary tumors in rats.
    Sylvester PW; Ip C; Ip MM
    Cancer Res; 1986 Feb; 46(2):763-9. PubMed ID: 3079669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation of growth of carcinogen-induced mammary cancers in rats by thyrotropin-releasing hormone.
    Chen HJ; Bradley CJ; Meites J
    Cancer Res; 1977 Jan; 37(1):64-6. PubMed ID: 401473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is there any association between the pharmacologic control of prolactin release and its action on mammary carcinogenesis in the rat?
    Feuer G; Kellen JA; Kovacs K
    Clin Endocrinol (Oxf); 1977; 6 Suppl():57S-63S. PubMed ID: 101323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation of the neuroendocrine system to the development and growth of experimental mammary tumors.
    Meites J
    J Neural Transm; 1980; 48(1):25-42. PubMed ID: 6106045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of prolactin in the development of mammary gland tumors induced by dimethylbenzanthracene].
    Dedov II; Demina NA
    Biull Eksp Biol Med; 1980 Sep; 90(9):348-50. PubMed ID: 6775709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melatonin increases the survival time of animals with untreated mammary tumours: neuroendocrine stabilization.
    Saez MC; Barriga C; Garcia JJ; Rodriguez AB; Masot J; Duran E; Ortega E
    Mol Cell Biochem; 2005 Oct; 278(1-2):15-20. PubMed ID: 16180084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of prenatal or neonatal administration of 2-bromo-alpha-ergocryptine on pituitary prolactin secretion and normal and neoplastic mammary growth in adult mice.
    Nagasawa H; Yanai R
    J Endocrinol Invest; 1978 Jul; 1(3):273-6. PubMed ID: 583157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of high hoses of estrogen on prolactin-binding activity and growth of carcinogen-induced mammary cancers in rats.
    Kledzik GS; Bradley CJ; Marshall S; Campbell GA; Meites J
    Cancer Res; 1976 Sep; 36(9 pt.1):3265-8. PubMed ID: 824050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.